We seeded primary CLL lymphocytes originating from CLL patients on OP9 cells expressing the ligand DLL1 (OP9-DL1) or on control OP9 cells expressing GFP (OP9-GFP). Here, DLL1 is linked to B-cell chronic lymphocytic leukemia.